Goldman Sachs’s Coya Therapeutics COYA Stock Holding History

Goldman Sachs’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$153K	Buy	+26,180	New	+$121K	﹤0.01%	6265

Other funds holding COYA

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Goldman Sachs's COYA Position: Q2 2026 in Review

Goldman Sachs opened a new position in Coya Therapeutics (COYA) in Q2 2026: 26,180 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #6265 among its holdings.

54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

Goldman Sachs held 26,180 shares of Coya Therapeutics worth $153K as of Q2 2026.
Coya Therapeutics was a new Goldman Sachs position in Q2 2026.
Coya Therapeutics made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6265 holding.
54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.